Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06242730
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2024-01-09
Brief Title:
Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DOXY-MEN
Brief Summary:
The study aims at assessing effectiveness of offering event-driven Doxy PEP and 4CMenB immunization in MSMTGW at high STI risk It plans to offer this STI prevention package to all MSMTGW in the SHCS who are at risk of STI and then comparing 12-months STI incidence between those accepting and those not accepting the prevention package The proposal further hosts two interesting sub-studies One assessing potential effect of Doxy PEP on the microbiome and the other one assessing potential impact of Doxy PEP on TP MG and CT resistance
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None